The Chinnapen Lab, located in Boston, MA, is a cutting-edge research facility focused on developing innovative technologies to overcome cellular membrane barriers and improve drug delivery. Led by Principal Investigator Daniel Chinnapen, PhD, the lab collaborates with experts in various disciplines, including organic chemistry and in vivo biology, to develop next-generation oral biologic drugs and treatments for diseases affecting the brain. Their research aims to address the challenges of transporting biologics across the blood-brain barrier and enhancing the oral bioavailability of large therapeutic peptides.
With a strong emphasis on understanding cellular mechanisms and lipid chemistry, the Chinnapen Lab is dedicated to advancing the field of biotechnological drug development. Their work includes developing novel approaches for lysosomal disorders and investigating the role of the blood-brain barrier in obesity. By partnering with industry experts and utilizing a multidisciplinary approach, the lab strives to develop biotherapeutics that can effectively cross highly-selective cellular barriers and revolutionize drug delivery systems.
Generated from the website